Alivus Life Sciences Limited (NSE:ALIVUS)
India
· Delayed Price · Currency is INR 1,016.35
-39.05 (-3.70%)
Feb 21, 2025, 9:15 AM IST
Alivus Life Sciences Revenue
Alivus Life Sciences had revenue of 6.42B INR in the quarter ending December 31, 2024, with 12.05% growth. This brings the company's revenue in the last twelve months to 22.74B, down -3.97% year-over-year. In the fiscal year ending March 31, 2024, Alivus Life Sciences had annual revenue of 22.83B with 5.64% growth.
Revenue (ttm)
22.74B
Revenue Growth
-3.97%
P/S Ratio
5.48
Revenue / Employee
11.29M
Employees
2,014
Market Cap
124.54B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,398.38B |
| Tata Consultancy Services | 2,520.82B |
| HDFC Bank | 2,702.59B |
| Bharti Airtel | 1,627.08B |
| ICICI Bank | 1,755.26B |
| Infosys | 1,635.60B |
| State Bank of India | 3,409.52B |
| Hindustan Unilever | 626.61B |